CIK 0001768224 · Accelerated filer<br>Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 8589002660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 4 Planned sale Chief Scientific Officer & COO sold 12,000 shares at $20.76 ($249,121)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
Page 4 of 21 · 416 filings